LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Bone Biologics Corp

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERBBLG
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / BBLG COVERAGE

What’s moving Bone Biologics Corp now

Current reporting with the operating signal separated from the noise.

01
TradingKey

Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Investors are testing whether Bone Biologics Corp’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Stock Titan

Bone Biologics Corp SEC Filing (Jul 27, 2026)

The story matters when it changes Bone Biologics Corp’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest BBLG filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-02 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-23 · Period 2026-07-23SEC ↗8-KMaterial company eventFiled 2026-07-16 · Period 2026-07-15SEC ↗8-KMaterial company eventFiled 2026-07-09 · Period 2026-07-07SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-07-02 · Period 2026-07-02SEC ↗EFFECTOfficial SEC filingFiled 2026-07-24SEC ↗
EARNINGS / QUARTERLY TRACKER

Bone Biologics Corp, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.